Smart Pill Technology Market Latest Updated Report 2024-2031

"Smart Pill Technology Market" in terms of revenue was estimated to be worth $3.92 billion in 2023 and is poised to reach $9.21 billion by 2031, growing at a CAGR of 10.24% from 2024 to 2031 according to a new report by InsightAce Analytic.

Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1485

Latest Drivers Restraint and Opportunities Market Snapshot:

Key factors influencing the smart pill technology market are:
• Technological Advancements
• increasing colon cancer rates
• Increasing elderly population

The following are the primary obstacles to the smart pill technology market 's expansion:
• The high price tag for clever drugs
• Strict governmental rules
• Patient confidentiality concerns

Future expansion opportunities for the smart pill technology market include:
• Investment research and development
• Rising interest in cutting-edge medication delivery systems
• Growing demand for noninvasive monitoring and diagnostic technologies

Market Analysis:

Smart pills are an ingestible medical device that includes sensors, cameras, patches, and trackers. They are designed to improve diagnostics, patient monitoring, and targeted drug delivery. Appropriate reimbursement coverage in designated nations is anticipated to be a key component that augments the smart pill market's growth throughout the forecast timeframe. The demand for a speedier method of medication development is another optimistic sign for the future of the smart pill sector.

List of Prominent Players in the Smart Pill Technology Market:
• Chongqing Jinshan Science Technology (Group) Co., Ltd
• RF Co., Ltd (Japan)
• etectrx (US)
• BodyCap (France)
• CapsoVision,Inc. (US)
• Medtronic plc (US)
• Check-Cap Ltd. (Israel)
• IntroMedic (South Korea)
• ANX Robotica Corp. (US)
• Olympus Corporation (Japan)
• Shenzen Jifu Medical Technology Co., Ltd (China)
• Otsuka America Pharmaceutical, Inc. (US)

Recent Developments:
• In January 2024, etectRx, Inc. (etectRx) reported that the number of ingestions of its ID-Cap System digital pill has exceeded 10,000. This is a big deal for the company, which has a reputation for providing data to track patient's adherence to their oral medications accurately and has shown strong results.
• In November 2023, Check-Cap Ltd. announced that ISS, a prominent independent proxy advisory firm, has advised that at the forthcoming Annual General Meeting of Shareholders.
• In January 2024, AnX Robotica is pleased to announce that NaviCam ProScanTM has received FDA clearance. The company is a leader in cutting-edge gastrointestinal visualization technologies. After passing the FDA's stringent De Novo Submission Process, ProScan is now the first artificial intelligence-assisted reading tool specifically developed to assist reviewers of small intestine capsule endoscopy images taken of adults with suspicion of small intestinal bleeding.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1485

Smart Pill Technology Market Dynamics:
Market Drivers: Technological Advancements
With the advancements in capsule endoscope technology, the smart pill industry is expected to continue growing. Future technological developments in the finest smart pill available, such as bioelectronics, miniaturization, microprocessor availability, and micro-cameras, are anticipated to bring lucrative prospects. Movements toward patient-centered care and individualized medicine are congruent with the trend toward less intrusive diagnostic procedures. This encourages the use of smart medicines since it gives patients more control over their healthcare and empowers them. Patients can keep tabs on their health issues and the efficacy of their therapies with the help of smart pill technology.

Challenges: High Price Tag for Clever Drugs
The smart pill industry is expected to face challenges due to the increasing complexity of these products, which is expected to drive up their prices substantially. Spending much money on research and development is necessary to build and perfect the technology that powers smart medicines. Methods such as data analysis algorithms, miniature cameras, wireless connectivity, and sensor designs are all part of the process. These research endeavors drive up intelligent pill prices. Additional technologically ineffective capsule endoscopes might be a problem for the smart pill industry.

North America is Expected to Grow with the Highest CAGR During the Forecast Period
The smart pill technology market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. This is because of improved healthcare technology, a rise in colorectal cancer rates, and the green light from regulators for new products. Regulatory approval of new products and an increase in colorectal cancer cases are two elements expected to fuel the expansion of the smart pill market in the region over the forecast period.

Segmentation of Smart Pill Technology Market-
By Application-
• Capsule Endoscopy
• Targeted Drug Delivery
• Vital Sign Monitoring

By Target Area-
• Esophagus
• Small Intestine
• Large Intestine
• Stomach

By Disease Indication
• Barrett'S Esophagus
• Small Bowel Diseases
• Colon Cancer
• Others

By End User-
• Hospitals and Clinics
• Diagnostic Centres
• Research Centres

By Region-
North America-
• The US
• Canada
• Mexico

Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America-
• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/1485

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis of key market insights in a timely and cost-effective manner.

This release was published on openPR.